Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT03298802
PHASE3

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

Sponsor: The University of Texas Medical Branch, Galveston

View on ClinicalTrials.gov

Summary

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.

Official title: Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide: a Randomized Clinical Trial

Key Details

Gender

FEMALE

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

453

Start Date

2017-11-21

Completion Date

2025-04-22

Last Updated

2026-06-24

Healthy Volunteers

No

Interventions

DRUG

Hydrochlorothiazide 50mg Tablet

Hydrochlorothiazide 50 mg per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum.

DRUG

Placebo Tablet

Placebo per os once daily as soon as the subjects can tolerate sips of water after delivery and for a total of fourteen days postpartum

Locations (2)

St. David's North Austin Medical Center

Austin, Texas, United States

University of Texas Medical Branch

Galveston, Texas, United States